13F filing recap · Q3 2025

What did Brave Warrior Advisors buy in Q3 2025?

Reported stock-position changes between this filing and the previous one.

Stock value

$4.31B

Positions

Estimated turnover

20.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

Quarter in review

Brave Warrior Advisors opened a new position in Kinetik Holdings and exited S&P Global, Texas Instruments, and UnitedHealth Group. The firm substantially increased its Elevance Health stake while substantially trimming Capital One Financial and D.R. Horton. It also moderately reduced TD Synnex, Ryanair Holdings, and Millrose Properties, with smaller trims across several other holdings including OneMain Holdings, Lennar, and Primerica.

New positions

KNTKKinetik Holdings Inc.$68.77Mreported value+1.61M shares

Increased positions

ELVElevance Health, Inc.$592.60Mreported value+724.3K shares+65.3%SLMSlm Corp$322.73Mreported value+1.12M shares+10.6%MPLXMplx LP$223.15Mreported value+192.4K shares+4.5%FNFFidelity National Financial, Inc.$211.07Mreported value+2.2K shares

Reduced positions

SNXTD Synnex Corporation$536.33Mreported value-493.3K shares-13.1%OMFOnemain Holdings, Inc.$440.06Mreported value-75.8K shares-1.0%ANAutonation, Inc.$265.60Mreported value-467 shares-0.0%LENLennar Corp /new/$252.77Mreported value-151.6K shares

Exited positions

UNHUnitedHealth Group Incorporated$467.6Kprior reported value-1.5K shares-100.0%SPGIS&P Global Inc.$211.4Kprior reported value-401 shares-100.0%TXNTexas Instruments Incorporated$209.7Kprior reported value-1.0K shares-100.0%